Yufeng Lu

503 total citations
15 papers, 424 citations indexed

About

Yufeng Lu is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Yufeng Lu has authored 15 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Yufeng Lu's work include Autophagy in Disease and Therapy (2 papers), Cancer-related molecular mechanisms research (2 papers) and Eosinophilic Esophagitis (1 paper). Yufeng Lu is often cited by papers focused on Autophagy in Disease and Therapy (2 papers), Cancer-related molecular mechanisms research (2 papers) and Eosinophilic Esophagitis (1 paper). Yufeng Lu collaborates with scholars based in China. Yufeng Lu's co-authors include Liubing Li, Yangyun Wang, Liqin Shen, Zonggang Xie, Jie Zhang, Jun Gu, Li−Na Zhu, Leshuai W. Zhang, Shi‐Xun Ma and Yong Wang and has published in prestigious journals such as ACS Applied Materials & Interfaces, Molecular and Cellular Biochemistry and Aging.

In The Last Decade

Yufeng Lu

15 papers receiving 421 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yufeng Lu 130 112 97 66 61 15 424
Muhammad Sarfraz 224 1.7× 121 1.1× 113 1.2× 35 0.5× 42 0.7× 30 594
Carlos Medina 104 0.8× 120 1.1× 119 1.2× 31 0.5× 46 0.8× 16 531
Qiujing Li 198 1.5× 165 1.5× 98 1.0× 49 0.7× 37 0.6× 18 686
Mitra Korani 122 0.9× 77 0.7× 80 0.8× 24 0.4× 76 1.2× 19 523
Hadeer A. Aglan 85 0.7× 61 0.5× 64 0.7× 33 0.5× 28 0.5× 32 407
Hemen Moradi‐Sardareh 113 0.9× 76 0.7× 82 0.8× 32 0.5× 22 0.4× 29 357
Panfei Xing 142 1.1× 52 0.5× 182 1.9× 30 0.5× 55 0.9× 19 640
Zanko Hassan Jawhar 110 0.8× 68 0.6× 64 0.7× 25 0.4× 34 0.6× 30 340
Yuqian Cui 225 1.7× 87 0.8× 48 0.5× 16 0.2× 41 0.7× 31 731
Haowen Li 187 1.4× 118 1.1× 112 1.2× 23 0.3× 30 0.5× 34 516

Countries citing papers authored by Yufeng Lu

Since Specialization
Citations

This map shows the geographic impact of Yufeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufeng Lu more than expected).

Fields of papers citing papers by Yufeng Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufeng Lu. The network helps show where Yufeng Lu may publish in the future.

Co-authorship network of co-authors of Yufeng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yufeng Lu. A scholar is included among the top collaborators of Yufeng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufeng Lu. Yufeng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gao, Guangyu, et al.. (2022). miRNA-142-3p functions as a potential tumor suppressor directly targeting FAM83D in the development of ovarian cancer. Aging. 14(8). 3387–3399. 5 indexed citations
2.
Lu, Yufeng, et al.. (2020). Correlation between Claudin-18 expression and clinicopathological features and prognosis in patients with gastric cancer. Journal of Gastrointestinal Oncology. 11(6). 1253–1260. 13 indexed citations
3.
Wang, Wenyuan, et al.. (2020). Helicobacter pylori infection increases the risk of metabolic syndrome in pregnancy: a cohort study. Annals of Translational Medicine. 8(14). 875–875. 11 indexed citations
4.
Wang, Wenyuan, et al.. (2020). Siderophores induce mitophagy-dependent apoptosis in platelets. Annals of Translational Medicine. 8(14). 879–879. 8 indexed citations
5.
Ma, Shi‐Xun, Yan Chen, Yifeng Chen, et al.. (2018). Short-term outcomes of robotic-assisted right colectomy compared with laparoscopic surgery: A systematic review and meta-analysis. Asian Journal of Surgery. 42(5). 589–598. 32 indexed citations
6.
Li, Liubing, Yufeng Lu, Yuhao Zhao, et al.. (2018). Fabrication and Reduction of pH Dual Bio-Responsive Poly(ether-urethane) Nanocarriers for Targeted Drug Delivery. Nanoscience and Nanotechnology Letters. 10(1). 13–22. 2 indexed citations
7.
Zhu, Huiping, Xiaolin Ge, Yufeng Lu, et al.. (2018). Nedaplatin‑based chemotherapy regimens combined with concurrent radiotherapy as first‑line treatment for stage II‑III esophageal squamous cell carcinoma. Oncology Letters. 17(1). 594–602. 10 indexed citations
8.
Zhuang, Zhixiang, et al.. (2017). Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting. Artificial Cells Nanomedicine and Biotechnology. 46(8). 1–8. 37 indexed citations
9.
Yuan, Yuan, Shi‐Xun Ma, Yongmei Qi, et al.. (2016). Quercetin inhibited cadmium-induced autophagy in the mouse kidney via inhibition of oxidative stress. Journal of Toxicologic Pathology. 29(4). 247–252. 39 indexed citations
10.
Wang, Yangyun, Li−Na Zhu, Yong Wang, et al.. (2016). Ultrasensitive GSH-Responsive Ditelluride-Containing Poly(ether-urethane) Nanoparticles for Controlled Drug Release. ACS Applied Materials & Interfaces. 8(51). 35106–35113. 54 indexed citations
11.
Li, Liubing, Jun Gu, Jie Zhang, et al.. (2015). Injectable and Biodegradable pH-Responsive Hydrogels for Localized and Sustained Treatment of Human Fibrosarcoma. ACS Applied Materials & Interfaces. 7(15). 8033–8040. 100 indexed citations
12.
Xue, Yuzheng, Yanmin Wu, Yufeng Lu, et al.. (2013). DLC-1 is a candidate biomarker methylated and down-regulated in pancreatic ductal adenocarcinoma. Tumor Biology. 34(5). 2857–2861. 10 indexed citations
13.
Xue, Yuzheng, Zongliang Liu, Yanmin Wu, et al.. (2012). Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance. Tumor Biology. 34(2). 895–899. 24 indexed citations
15.
Liu, Zongliang, et al.. (2007). [Effect and mechanism of reduced glutathione treatment on liver functional impairments in experimental severe acute pancreatitis in rats].. PubMed. 15(11). 854–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026